<DOC>
	<DOCNO>NCT02611609</DOCNO>
	<brief_summary>A study examine safety ( potential efficacy ) adult stem cell investigational product , MultiStem , adult Acute Respiratory Distress Syndrome ( ARDS ) . The primary hypothesis MultiStem safe ARDS patient .</brief_summary>
	<brief_title>A Phase 1/2 Study Assess MultiStemÂ® Therapy Acute Respiratory Distress Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Newborn</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<mesh_term>Acute Lung Injury</mesh_term>
	<criteria>Diagnosis moderate severe ARDS , define Berlin definition , require endotracheal tracheal tube Able receive investigational medicinal product within 96 hour meet last ARDS diagnosis criterion Concurrent illness shorten life expectancy le 6 month Other serious medical psychiatric illness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>